Charles River Laboratories International, Inc. (CRL)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Charles River Laboratories International, Inc. (CRL)
Go deeper and ask any question about CRL
Company Performance
Current Price
as of Sep 13, 2024$198.61
P/E Ratio
23.48
Market Cap
$10.25B
Description
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Metrics
Overview
- HQWilmington, MA
- SectorCommercial Services
- IndustryMiscellaneous Commercial Services
- TickerCRL
- Price$198.61+2.21%
Trading Information
- Market Cap$10.25B
- Float98.86%
- Average Daily Volume (1m)561,508
- Average Daily Volume (3m)653,920
- EPS$8.51
Company
- Revenue$4.08B
- Rev Growth (1yr)-3.19%
- Net Income$89.99M
- Gross Margin32.69%
- EBITDA Margin24.92%
- EBITDA$255.69M
- EV$13.42B
- EV/Revenue3.29
- P/E23.48
- P/S2.53